significant cancer burden, with approximately 10,000 new cancer diagnoses of each in the UK per year [8]. These factors combined make visible haematuria and the malignancies that underlie it, an ideal target for a mass media public health campaign. The primary objective of this paper was to assess the impact and longevity of the ‘Be clear on cancer: blood in campaign on cancer diagnosis and referral burden. pee’ Methods A retrospective cohort study design was used; for two distinct time periods, August 2012 to May 2013 and August 2013 to May 2014, all referrals deemed to be at risk of urological cancer by the referring primary health care physician to Imperial College NHS Healthcare Trust (ICHT) were screened. Data points collected were: age and sex of the patient, whether the referral was for visible haematuria, non-visible haematuria or another non-haematuria related suspected urological cancer. In addition to referral data, hospital episode data of all new renal cell, and upper and lower tract transitional cell carcinoma for the same time periods was obtained, this second dataset set comprised all diagnoses for the periods in question including those not identified through the pathway. ‘suspected cancer’ The 2012-13 time period was used as the comparator group to allow assessment of the impact of the on cancer: blood in public health campaign that ran from ‘Be clear pee’ October to November 2013. A comparison of the August to May time periods (2012-13 versus 2013-14) was used to gain an understanding of the longevity of effect. When undertaking comparisons to
significant cancer burden, with approximately 10,000 new cancer diagnoses of each in the UK per year [8]. These factors combined make visible haematuria and the malignancies that underlie it, an ideal target for a mass media public health campaign. The primary objective of this paper was to assess the impact and longevity of the ‘Be clear on cancer: blood in pee’ campaign on cancer diagnosis and referral burden. Methods A retrospective cohort study design was used; for two distinct time periods, August 2012 to May 2013 and August 2013 to May 2014, all referrals deemed to be at risk of urological cancer by the referring primary health care physician to Imperial College NHS Healthcare Trust (ICHT) were screened. Data points collected were: age and sex of the patient, whether the referral was for visible haematuria, non-visible haematuria or another non-haematuria related suspected urological cancer. In addition to referral data, hospital episode data of all new renal cell, and upper and lower tract transitional cell carcinoma for the same time periods was obtained, this second dataset set comprised all diagnoses for the periods in question including those not identified through the ‘suspected cancer’ pathway. The 2012-13 time period was used as the comparator group to allow assessment of the impact of the ‘Be clear on cancer: blood in pee’ public health campaign that ran from October to November 2013. A comparison of the August to May time periods (2012-13 versus 2013-14) was used to gain an understanding of the longevity of effect. When undertaking comparisons to
A%20national%20haematuria%20campaign.docx